ImClone Rises

Ask Jeeves advances; Hasbro slips; plus more of today's stocks in the news

ImClone Systems (IMCL ) says the FDA accepted for review its Chemistry, Manufacturing and Controls supplemental Biologics License Application for licensure of an Erbitux manufacturing facility. Separately, Banc of America initiated coverage with buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.